Patient Case Study – Multiple Myeloma: Medical Profile | ZOMETA®

View videos on bone
metastases and the ZOMETA
mechanism of action

Learn more about the ZOMETA(zoledronic acid) mechanism of action

For non-U.S. Healthcare Professionals: Get information about ZOMETA and its product characteristics

Learn more about ZOMETA product characteristics

ZOMETA Patient Case Study: Multiple Myeloma

ZOMETA® Multiple Myeloma Patient Case Study – Marie

Marie T.

Aged 62 years
Lives and works on a family farm
Enjoys walking her dogs with her husband

Page

1 2 3

Initial diagnosis

Marie presented with a 1-month history of back pain, headache, and fatigue
Physical examination revealed pallor and tenderness to palpation in the scalp and over the L3 vertebra
Several laboratory values were analyzed
- — Hemoglobin 10.2 g/dL in complete blood count
- — Monoclonal globulin spike and IgG peak of 7.1 g/dL by serum protein electrophoresis
- — Serum calcium 10.0 mg/dL
- — Serum creatinine slightly elevated (1.4 mg/dL), with normal creatinine clearance (85 mL/min)
Bone marrow biopsy revealed 48% atypical plasma cells
Plain films revealed 2 lytic lesions in the skull and additional lesions in the L3 and L4 vertebrae
Diagnosis: stage III multiple myeloma

Page

1 2 3

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US flag at the top right corner of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.